Results 191 to 200 of about 53,933 (241)

Dysregulated bile acid metabolism as a novel player in gout progression: emerging therapeutic strategies. [PDF]

Front Endocrinol (Lausanne)
Sun H, Yang L, Sun Y, Zhang X, Sun X, Zhao X, Sun H, Zhang Q, Yan G, Wang X.   +9 more
europepmc   +1 more source

Relevance of FXR-p62/SQSTM1 pathway for survival and protection of mouse hepatocytes and liver, especially with steatosis [PDF]

Michitaka Ozaki, null Yimin, Sanae Haga
core   +1 more source

Metabolic syndrome and kidney dysfunction: emerging molecular and cellular mechanisms at the metabolic-renal interface. [PDF]

Front Endocrinol (Lausanne)
Marshall WR, Green D, Sinha S, Kalra PA.
europepmc   +1 more source

Comparative analysis of OECD guideline data and Tox21 assays to improve reproductive and developmental toxicity prediction. [PDF]

Sci Rep
Kwon HJ, Lee H, Lee S, Ko W, Yun SJ, Uesawa Y, Jung J.   +6 more
europepmc   +1 more source

Danggui-Baishao herb pair protects against dextran sulfate sodium-induced colitis by modulating the Wnt/β-catenin pathway. [PDF]

World J Gastroenterol
Xu T, Hou WX, Yang ST, Shao YP, Wang J, Han TT, Li JN.   +6 more
europepmc   +1 more source

Emerging Therapeutics for Primary Biliary Cholangitis. [PDF]

Korean J Gastroenterol
Cho EJ.
europepmc   +1 more source

Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXR. [PDF]

eGastroenterology
Henry ZR, Maliha S, Basaly V, Yang Z, Taylor RE, Otersen K, Meadows V, Rizzolo D, Stofan M, Bhattacharya A, Zhou P, Brinker A, Yang I, Zhang L, Joseph LB, Buckley B, Kong B, Guo GL.   +17 more
europepmc   +1 more source

Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach [PDF]

core   +1 more source

A critical review of natural products driven correction of bile acid dysregulation: a therapeutic strategy for nonalcoholic fatty liver disease. [PDF]

Front Pharmacol
Peng Q, Hao L, Li S, Yu F, Li N, Hu X.
europepmc   +1 more source